BREAKING
Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 hour ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 21 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 hour ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 21 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago
ADVERTISEMENT
AlphaGraphs

Estee Lauder (EL) Q2 2024 Earnings: Key financials and quarterly highlights

The Estée Lauder Companies Inc. (NYSE: EL) reported second quarter 2024 earnings results today. Net sales declined 7% to $4.28 billion from the prior-year period. Organic net sales fell 8%. Net earnings was $313 million, or $0.87 per share, compared to $394 million, or $1.09 per share, last year. Adjusted EPS was $0.88. Both revenue […]

$EL February 5, 2024 1 min read

The Estée Lauder Companies Inc. (NYSE: EL) reported second quarter 2024 earnings results today.

Net sales declined 7% to $4.28 billion from the prior-year period. Organic net sales fell 8%.

Net earnings was $313 million, or $0.87 per share, compared to $394 million, or $1.09 per share, last year. Adjusted EPS was $0.88.

Both revenue and earnings beat expectations, sending the stock soaring over 16% in premarket hours on Monday.  

For the third quarter of 2024, reported net sales are forecasted to increase between 3-5% versus the prior-year period. Adjusted EPS is expected to range between a decrease of 18% and an increase of 3% on a constant currency basis.

ADVERTISEMENT

Prior performance

ADVERTISEMENT